Review time of oncology drugs and its underlying factors

Introduction: How the launch delay of drugs and other factors of interest can influence the length of the review period by drug agencies is ...

Review time of oncology drugs and its underlying factors - PubMed

Introduction: How the launch delay of drugs and other factors of interest can influence the length of the review period by drug agencies is ...

Effects of factors of interests on the review time. - ResearchGate

Introduction: How the launch delay of drugs and other factors of interest can influence the length of the review period by drug agencies is still unknown, ...

Barriers in access to oncology drugs — a global crisis - Nature

Notably, the way drug prices are negotiated is one of the major factors ... the approval of 15 fewer drugs over a three-decade period. Although ...

An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on ...

Cancer Drug Pricing. The pricing of cancer drugs involves several factors. The most important factor is what drug manufacturers believe the ...

Drug Pricing and Value in Oncology - Wharton Faculty Platform

(2016) studied prices to commercially insured patients for 24 orally administered cancer drugs for the period 2007–13. They found that on average cancer drug ...

Trial-level factors affecting accrual and completion of oncology ...

The median cost of clinical trials for oncology drugs approved by the Federal Drug ... Also, since most of the studies in this review focused on adult oncology ...

Time-of-day effects of cancer drugs revealed by high-throughput ...

Variability throughout the day depends on the drug and cell model. The presence of a robust circadian clock combined with drugs that efficiently ...

Cancer Drug Price and Novelty in Mechanism of Action

Design, Setting, and Participants This cross-sectional study included all cancer drugs approved by the US Food and Drug Administration (FDA) ...

The reimbursement decision speed for oncology new drugs in China ...

To promote the accessibility of new drugs, in 2015, China rolled out initiatives in the drug regulatory system toward faster delivery of new drugs with high ...

Targeted Therapy for Cancer - NCI

But most of the time, your tumor will need to be tested to see if it ... Look up your type of cancer on the list of targeted therapy drugs ...

Molecular Oncology - Wiley Online Library

The journal considers Research Articles from the fields of basic, translational, and clinical cancer research. We also publish Review Articles, Commentaries and ...

Cancer chemotherapy and beyond: Current status, drug candidates ...

The side effects of these drugs may depend on many factors and variables ... The European Medicines Agency review of Tegafur/Gimeracil/Oteracil ...

Journal of Experimental & Clinical Cancer Research: Home page

The vital component of the TME is tumor-associated macrophages (TAMs), which are usually associated with poor prognosis and drug resistance, including ...

American Association for Cancer Research - AACR Journals

The article titled, Modeling Drug Responses and Evolutionary Dynamics using Patient-Derived Xenografts Reveals · Read the article titled, Modeling Drug ...

Characteristics of Cost-effectiveness Studies for Oncology Drugs ...

In this analysis of cost-effectiveness studies on oncology drugs, we found that the largest factor associated with whether a drug was found to ...

How chemotherapy works - Cancer Research UK

Chemotherapy kills cells that are in the process of dividing into 2 new cells. It damages the genes inside the nucleus. Different chemotherapy drugs will do ...

Cancer treatment - Mayo Clinic

Cancer treatment includes surgery, radiation, medicines and other therapies. The goal of cancer treatment is to cure or shrink a cancer or stop it from ...

Side effects of chemotherapy | Canadian Cancer Society

A drug reaction does not usually happen at home after treatment. Some drugs are more likely to cause an allergic reaction over time (such as carboplatin) while ...

Behind the Shortage Keeping Cancer Patients From Chemo

Key drugs have been in scarce supply, revealing a deep crisis in the generic drug industry.